Skip to main content

Table 3 Wound healing, and Rutherford class 0–3 at 1, 6, 12, 36, and 60 months

From: Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience

Outcome Total PCCs PBMNCs P
Complete wound healing, n (%)
 At enrollment 0/145 0/71 0/74 1.000
 At 1 months 13/145 6/71 7/74 .846
 At 6 months 85/140 40/69 45/71 .512
 At 12 months 111/128 58/68 53/60 .613
 At 36 months 86/90 50/51 36/39 .880
 At 60 months 47/47 34/34 13/13 .292
Rutherford class 0–3, n (%)
 At enrollment 0/160 0/82 0/78 1.000
 At 1 month 19/160 10/82 9/78 .898
 At 6 months 89/153 43/78 46/75 .437
 At 12 months 120/139 64/77 56/62 .219
 At 36 months 87/93 50/53 37/40 1.000
 At 60 months 47/48 34/35 13/13 1.000
  1. PCCs purified CD34+ cells, PBMNCs peripheral blood mononuclear cells